Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis.

Details

Ressource 1Download: 32425357_BIB_36FA44B46F63.pdf (309.27 [Ko])
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_36FA44B46F63
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis.
Journal
Annals of oncology
Author(s)
Doms J., Prior J.O., Peters S., Obeid M.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Publication state
Published
Issued date
09/2020
Peer-reviewed
Oui
Volume
31
Number
9
Pages
1273-1275
Language
english
Notes
Publication types: Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Keywords
Antibodies, Monoclonal, Humanized/adverse effects, Humans, Immune Checkpoint Inhibitors, Immunotherapy, Myocarditis/chemically induced, Myocarditis/drug therapy
Pubmed
Web of science
Open Access
Yes
Create date
14/06/2020 19:21
Last modification date
25/01/2024 7:34
Usage data